- Home
- HTB vs ORGO Comparison
HTB vs ORGO Comparison
Compare HTB & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTB
- ORGO
- Stock Information
- Founded
- HTB 1926
- ORGO 1985
- Country
- HTB United States
- ORGO United States
- Employees
- HTB N/A
- ORGO N/A
- Industry
- HTB
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- HTB
- ORGO Health Care
- Exchange
- HTB NYSE
- ORGO Nasdaq
- Market Cap
- HTB 597.7M
- ORGO 533.9M
- IPO Year
- HTB N/A
- ORGO N/A
- Fundamental
- Price
- HTB $35.57
- ORGO $5.34
- Analyst Decision
- HTB Buy
- ORGO Buy
- Analyst Count
- HTB 1
- ORGO 2
- Target Price
- HTB $43.00
- ORGO $5.50
- AVG Volume (30 Days)
- HTB 38.1K
- ORGO 1.7M
- Earning Date
- HTB 04-24-2025
- ORGO 05-08-2025
- Dividend Yield
- HTB 0.68%
- ORGO N/A
- EPS Growth
- HTB N/A
- ORGO N/A
- EPS
- HTB 3.21
- ORGO N/A
- Revenue
- HTB $190,527,000.00
- ORGO $482,043,000.00
- Revenue This Year
- HTB $5.93
- ORGO $3.31
- Revenue Next Year
- HTB $4.06
- ORGO $12.50
- P/E Ratio
- HTB $10.92
- ORGO N/A
- Revenue Growth
- HTB N/A
- ORGO 11.29
- 52 Week Low
- HTB $26.93
- ORGO $2.17
- 52 Week High
- HTB $38.99
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- HTB N/A
- ORGO 67.16
- Support Level
- HTB N/A
- ORGO $5.14
- Resistance Level
- HTB N/A
- ORGO $5.42
- Average True Range (ATR)
- HTB 0.00
- ORGO 0.28
- MACD
- HTB 0.00
- ORGO 0.09
- Stochastic Oscillator
- HTB 0.00
- ORGO 85.09
About HTB HOMETRUST BANCSHARES INC
HomeTrust Bancshares Inc operates as a bank holding company. It engaged in the business of planning, directing and coordinating the business activities of the Bank. The Bank is a North Carolina state chartered bank and provides a range of retail and commercial banking products. Company's principal business consists of attracting deposits from the general public and investing those funds, along with borrowed funds, in commercial real estate loans, construction and development loans, commercial and industrial loans, equipment finance leases, municipal leases, loans secured by first and second mortgages on one-to-four family residences including home equity loans and other consumer loans.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.